As of Jan 20
| +0.26 / +1.13%|
The 6 analysts offering 12-month price forecasts for LeMaitre Vascular Inc have a median target of 25.00, with a high estimate of 26.00 and a low estimate of 21.00. The median estimate represents a +7.11% increase from the last price of 23.34.
The current consensus among 6 polled investment analysts is to Buy stock in LeMaitre Vascular Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.